The Effect of the Oral Bacterial Extract OM-85 BV on Asthma Control- a Prospective Study
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 1
Abstract
Aims: To identify the effect of the oral bacterial extract OM-85 on essential parameters of asthma control. Study Design: This was a double blind, prospective study, consistent of a 4 week run-in and a 24 week double blind period. Place and Duration of Study: An outpatient clinic, in collaboration with “St Andrew’s’’ General State Hospital in Patras/Greece, between October 2010 and April 2011. Methods: Patients (aged 15-57, N=130) with persistent allergic asthma, were assessed and divided accordingly, in three strata: Stratum I (not controlled asthma, NCA), stratum 2 (partly controlled asthma, PCA) and stratum 3 (controlled asthma, CA). At the end of the run-in period were randomized to receive additionally to their standard treatment (appropriate doses inhaled budesonide and formoterol), 7mg oral OM-85 BV or matching placebo. Primary end-point was the proportion of patients with controlled asthma in every group. Change from baseline budesonide, mean FEV1, PEF, daytime asthma symptoms score, night awakenings, rescue b2-agonist use and serum interferon-γ (INF-γ) levels were also recorded and included in the final analysis. Results: At the end of the 24 week follow up, stratum I patients, treated additionally with OM-85 BV, presented significantly higher proportion of subjects with controlled (28.09% versus 18.7%, P<0.001), and partly controlled asthma (57% versus 43.7%, (P= 0.04). Almost all patients demonstrated significant increases (P<0.001) from baseline in FEV1.The percentage change from baseline FEV1 was 21.8% for OM-85 BV versus 12.1% for the placebo group. Same tendencies were recorded in every stratum and concerned al secondary end points, despite a lower dose of budesonide. Conclusions: Patients treated additionally with OM-85 BV achieved better asthma control despite a lower dose of budesonide.
Authors and Affiliations
Antonios Christopoulos, Lilia Pandeli, Panagiotis Demopoulos
Keywords
Related Articles
- EP ID EP348620
- DOI 10.9734/BJMMR/2014/4458
- Views 83
- Downloads 0
Comparison between PCR– based Single Tube Genotyping of Sickle Cell Disease and Alkaline Haemoglobin Electrophoresis
Background: Sickling test and haemoglobin solubility test are screening techniques used to detect the presence of haemoglobin S, but can't identify exact phenotype or genotype. Haemoglobin electrophoresis can determine t...
Applying the Health Belief Model Constructs to Determine Predictors of Dietary Behavior among High-School Students
Introduction: Healthy nutrition during adolescence and adulthood, compared with childhood, is considered important since the basal metabolic rate decreases with age and there is often a reduction of physical activities....
Outcomes of Older Children with Kawasaki Disease Who Received Intravenous Immunoglobulin Therapy with Delayed Use of Anti-inflammatory Drugs
Background: The prevalence of coronary artery lesions (CAL) is higher in older children compared with younger children. Anti-inflammatory drugs including aspirin appeared to have a negative impact on the suppressive effe...
Gastric Metastatis of Renal Cell Carcinoma Presenting as Polyps
Metastatic tumors of the stomach are very rare, with an incidence of 0, 2%- 0, 7% in the autopsy series. Malignant melanoma, carcinomas of breast, esophagus and lung are the most frequent primary tumor sites. The present...
Sapium ellipticum (Hochst.) Pax Leaf Extract: In-vitro Antioxidant Activities and Lethal Dose (LD50) Determination in Wistar Rats
Prior to this investigation, the LD50 and antioxidant activities of Sapium ellipticum leaf extract have not been reported, hence; the focus of this study. The LD50 of the extract was determined through three routes of ad...